Pfizer’s nasal spray for migraines is heading to pharmacies
The FDA has approved Pfizer’s zavegepant, a nasal spray for migraines that can ease pain in as few as 15 minutes.
“Digital detoxes” don’t work. Try these 4 skills instead
Digital distractions have become a ubiquitous part of work and life. But these distractions begin with emotional discomfort.
Breakthrough study discovers that psychedelics breach our neurons
Researchers have discovered that psychedelics can activate 5-HT2A receptors inside of cortical neurons, a possible cause of their therapeutic effects.
Psychedelics are helping dying patients overcome their existential distress
End of life patients face existential and spiritual challenges other patients do not. Psychedelics may be uniquely suited to helping them.
First: Spinal cord stimulation helps stroke survivors control arms again
Spinal cord stimulation has been shown to improve upper-limb mobility in stroke survivors for the first time.
DMT therapy appears effective for depression in phase 2 clinical trial
London-based Small Pharma has released positive top-line results for their phase 2a trial of DMT as an antidepressant.
Human-rat brain hybrid shows a way to cure blindness
New research has shown that human “mini brains” can integrate with damaged rat brains to perform functions related to sight.
New brain implant breaks record for turning thoughts into text
Stanford researchers have developed a brain-computer interface that allowed a woman to “type” 62 words per minute using only her thoughts.
New biomarker test accurately predicts who will respond to antidepressant
Alto Neuroscience’s depression drug seems effective in early trials, a proof-of-concept for biomarker-based design.
Brain experiment suggests that consciousness relies on quantum entanglement
Researchers possibly witnessed entanglement in the brain, indicating that some brain activity, like consciousness, operates on a quantum level.